Previous 10 | Next 10 |
Calumet Closes $325 Million Notes Offering, Recaps Recent Financing Activity - $675 million of capital raised since November 2021 - Proceeds of capital raises used to de-lever, fund renewable diesel business and manage debt maturities - Amended and extended revolving cre...
Calumet Specialty Products Partners, L.P. Announces Pricing of $325 Million Upsized Private Placement of 8.125% Senior Notes due 2027 PR Newswire INDIANAPOLIS , Jan. 12, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) (the "Part...
Calumet Specialty Products Partners, L.P. Announces $300 Million Private Placement of Senior Notes Due 2027 and Issues Notice of Conditional Redemption for its 7.75% Senior Notes due 2023 PR Newswire INDIANAPOLIS , Jan. 12, 2022 /PRNewswire/ -- Calumet Specialty ...
Calumet Provides Preliminary Year End 2021 Update - Year-end liquidity of approximately $333 million - Downtime in Montana and continued additive shortage in Performance Brands during the fourth quarter - Exceptional engineered fuel demand, record order backlog and suppl...
Calumet Announces Close of Renewable Hydrogen Project Financing PR Newswire INDIANAPOLIS , Jan. 4, 2022 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT, "Calumet") announced today that Montana Renewables LLC ("MRL") has closed the pre...
Calumet's plan for asset growth offers investors a unique opportunity for early investing in future financial growth. The stock price now in the middle teens is still relatively inexpensive. Calumet's vision races forward with significant financial advantages. For further de...
Calumet Specialty Products Partners, L.P. To Attend Investor Conferences PR Newswire INDIANAPOLIS , Nov. 30, 2021 /PRNewswire/ -- Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT, "Calumet") will participate in the Cowen 2021 Energy Summit and the Ban...
Pasithea Therapeutics (NASDAQ:KTTA) +172% adds Esketamine nasal spray to its clinic offerings in the U.K. Petros Pharmaceuticals (NASDAQ:PTPI) +99%. iSpecimen ISPC +99% is set to extend rally after contract win for COVID-19 research Qualigen Therapeutics (NASDAQ:QLGN) +72%. Aad...
Calumet Specialty Products Partners L.P. (NASDAQ:CLMT) traded today at a new 52-week high of $16.30. This new high was reached on below average trading volume as 129,000 shares traded hands, while the average 30-day volume is approximately 208,000 shares. Calumet Specialty Products Partn...
Calumet Specialty Products Partners (NASDAQ:CLMT) +2.8% pre-market after unveiling plans to carve out its Montana Renewables unit as an unrestricted pure-play renewables unit. Following a $300M investment from Oaktree Capital Management, Calumet says its operations in Montana now include...
News, Short Squeeze, Breakout and More Instantly...
Calumet Specialty Products Partners L.P. Company Name:
CLMT Stock Symbol:
NASDAQ Market:
Calumet, Inc. to Release Second Quarter 2024 Earnings on August 9, 2024 PR Newswire INDIANAPOLIS , July 26, 2024 /PRNewswire/ -- Calumet, Inc. (NASDAQ: CLMT) (the "Company," "Calumet," "we," "our" or "us"), announced today that it plans to report results for the ...
Calumet Specialty Products Partners, L.P. Completes Conversion to a C-Corporation PR Newswire Common Stock of Calumet, Inc. to Commence Trading on Nasdaq on Thursday, July 11 INDIANAPOLIS , July 10, 2024 /PRNewswire/ -- July 10, 2024 ...